| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Customer Officer
1 company
Dallan Murray last filed a Form 4 in March 2025, as Chief Customer Officer at SRPT. Dallan Murray's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 38,202 shares of SRPT. The SRPT filings lean toward selling, a net 3,635 shares.
Dallan Murray has 7 Form 4 filings on record from May 2024 to March 2025, all as Chief Customer Officer at Sarepta Therapeutics (SRPT), 2024–2025.
The 16 reported transactions were 7 tax withholdings, 4 option or other derivative awards, 3 option exercises and 1 stock award, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 1 sale worth about $509K.
The only open-market sale was 3,635 shares of SRPT at an average $140.00 on May 2, 2024, about $509K. Twelve months later SRPT was down 51%.
Shares as reported in the last Form 4 for each company; the most recent is from March 2025. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.